First Manhattan CO Pds Biotechnology Corp Transaction History

First Manhattan CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$7.76 - $14.35 $587,874 - $1.09 Million	75,757 Added 38.69%	271,576 $2.2 Million
Q3 2021 Nov 15, 2021	BUY	$9.33 - $17.08 $213,545 - $390,927	22,888 Added 13.24%	195,819 $2.92 Million
Q2 2021 Aug 16, 2021	BUY	$4.35 - $12.86 $103,808 - $306,891	23,864 Added 16.01%	172,931 $2.17 Million
Q1 2020 May 06, 2020	BUY	$0.67 - $3.04 $99,874 - $453,163	149,067 New	149,067 $108,000

4.22M

170K

6.7K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $38.1M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.